{"id":"W3157504641","doi":"10.1210/jendso/bvab048.019","title":"Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2)","year":2021,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Semaglutide; Overweight; Medicine; Tolerability; Placebo; Type 2 diabetes; Body mass index; Obesity; Weight loss; Internal medicine; Randomized controlled trial; Confidence interval; Diabetes mellitus; Physical therapy; Adverse effect; Endocrinology; Liraglutide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00150335,0.0006322043,0.001493967,0.0002647379,0.0002220439,0.0006116579,0.0004375183,0.0009255648,0.004332209],"category_scores_gemma":[0.001499272,0.0003683417,0.001247429,0.000248854,0.0002947738,0.0004536687,0.0003560446,0.001183224,0.0006361527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004061441,"about_ca_system_score_gemma":0.001015215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008323122,"about_ca_topic_score_gemma":0.001788947,"domain_scores_codex":[0.9994919,0.0002540618,0.00004718996,0.00008366307,0.00006574648,0.00005740912],"domain_scores_gemma":[0.9993024,0.0001807307,0.0002512717,0.00004433797,0.00005841165,0.0001629212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9106582,0.01239217,0.008257605,0.001500014,0.002139797,0.00007856999,0.00009721353,0.00069005,0.005664738,0.00008616249,0.00176405,0.05667144],"study_design_scores_gemma":[0.7674813,0.1881655,0.0377582,0.0002046413,0.001914401,0.0001251649,0.00005424421,0.000906791,0.001721438,0.0001485432,0.001486783,0.00003304877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929425,0.002831018,0.0002725475,0.0002058682,0.00006625634,0.001387371,0.0008789383,0.00005483935,0.001360804],"genre_scores_gemma":[0.991222,0.001598351,0.001158481,0.0007480455,0.00008768081,0.002398354,0.00110913,0.00001263943,0.001665252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004332209,"threshold_uncertainty_score":0.01449269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007206146587111358,"score_gpt":0.2366507703655843,"score_spread":0.229444623778473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}